ESMO Asia 2016 Congress

Oncology Meeting Resources

16 Dec - 19 Dec 2016, Singapore

ESMO Asia 2016 Square

The ESMO Asia Congress comprised both scientific and educational tracks prepared by an international scientific committee. There was a strong emphasis on state of the art science, including a call for abstracts, and the current standard of care across all major tumour types.

Abstracts, presentations and webcasts from the ESMO Asia 2016 Congress are now available here to ESMO members. The use of these presentations is for personal educational purposes only. ESMO thanks the authors for their generosity.

Useful Links





Format available

http://oncologypro.esmo.org/Meeting-Resourc...-burden-and-role-of-further-systemic-therapy

Date: 16 Dec 2016
Presenter: Paul Mainwaring
Resources: Presentation, Webcast

http://oncologypro.esmo.org/Meeting-Resourc...ia-2016-Congress/Difficult-anaplastic-glioma

Date: 16 Dec 2016
Presenter: Motoo Nagane
Resources: Presentation

http://oncologypro.esmo.org/Meeting-Resourc...016-Congress/Difficult-anaplastic-meningioma

Date: 16 Dec 2016
Presenter: Matthias Preusser
Resources: Presentation, Webcast

http://oncologypro.esmo.org/Meeting-Resourc...ulloblastoma-anaplastic-ependymoma-in-adults

Date: 16 Dec 2016
Presenter: Rakesh Jalali
Resources: Presentation, Webcast

http://oncologypro.esmo.org/Meeting-Resources/ESMO-Asia-2016-Congress/Introduction5

Date: 16 Dec 2016
Presenter: Ravindran Kanesvaran
Resources: Webcast

http://oncologypro.esmo.org/Meeting-Resourc...d-on-AXL-signaling-for-therapeutic-targeting

BackgroundOvarian cancer (OC) is a complex disease demonstrated by the heterogeneity in gene expression molecular subtypes (GEMS). Kinome enrichment analysis identifies a receptor tyrosine kinase (RTK)...

Date: 16 Dec 2016
Presenter: Ruby Huang
Resources: Abstract, Presentation, Webcast
Topics: Ovarian Cancer, Translational Research

http://oncologypro.esmo.org/Meeting-Resourc...E1-in-high-grade-serous-ovarian-cancer-HGSOC

BackgroundCyclin E1 protein is highly expressed in 30% of HGSOC, and while CCNE1 amplification provides a plausible mechanism in about half of cases, the driver and the clinical impact of high expression...

Date: 16 Dec 2016
Presenter: Diar Aziz
Resources: Abstract
Topics: Ovarian Cancer, Translational Research

http://oncologypro.esmo.org/Meeting-Resourc...nform-prognosis-and-clinical-decision-making

Date: 16 Dec 2016
Presenter: Axel Hillmer
Resources: Presentation, Webcast

http://oncologypro.esmo.org/Meeting-Resourc...rative-treatment-for-gastroesophageal-cancer

Date: 16 Dec 2016
Presenter: Ian Chau
Resources: Presentation, Webcast

http://oncologypro.esmo.org/Meeting-Resourc...ncer-More-precise-more-efficacious-and-safer

Date: 16 Dec 2016
Presenter: Florian Lordick
Resources: Presentation, Webcast